 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Trega Biosciences, Inc.
 |
Trega Biosciences, Inc. |
 |
 |
 |
PROFILE |
 |
When it comes to drug development, Trega Biosciences would rather provide the cleaning supplies than do the dirty work. Its iDiscovery technologies speed the discovery of new treatments by offering drug modeling programs and Trega's combinatorial chemistry libraries of potential drug candidates. One component of iDiscovery is IDEA, a computer model that predicts a drug's absorption, distribution, metabolism, and excretion properties to determine if it's worthy of being developed. Trega also develops drugs, but only through alliances; its partners include Novartis, which is working with the firm on new therapies for diabetes, obesity, and other conditions. LION Bioscience bought the company.
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
1999 Sales (mil.): 13.40
1-Yr. Sales Growth: 24.1%
Employees: 117
Revenue per employee: $114,529.91
KEY PEOPLE |
 |
Michael G. Grey
CEO
CONTACT INFO |
 |
9880 Campus Point Dr.
San Diego, CA 92121
US
Phone: 858-410-6500
Fax: 858-410-6501
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |